Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study-Reference-Cited by-同舟云学术

Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study

Published:2018-03-06 Issue:6 Volume:32 Page:1380-1392
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Stauder Reinhard,Yu Ge^ORCID,Koinig Karin A.,Bagguley Tim,Fenaux Pierre,Symeonidis Argiris,Sanz Guillermo^ORCID,Cermak Jaroslav,Mittelman Moshe,Hellström-Lindberg Eva,Langemeijer Saskia,Holm Mette Skov,Mądry Krzysztof,Malcovati Luca,Tatic Aurelia,Germing Ulrich,Savic Aleksandar,van Marrewijk Corine,Guerci-Bresler Agnès,Luño Elisa,Droste Jackie,Efficace Fabio,Smith Alex,Bowen David,de Witte Theo

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-018-0089-x.pdf

Reference35 articles.

1. Malcovati L, Hellstrom-Lindberg E, Bowen D, Ades L, Cermak J, Del Canizo C, et al. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. Blood. 2013;122:2943–64.

2. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079–88.

3. Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sole F, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120:2454–65.

4. Wildiers H, Heeren P, Puts M, Topinkova E, Janssen-Heijnen ML, Extermann M, et al. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014;32:2595–603.

5. Bottomley A, Pe M, Sloan J, Basch E, Bonnetain F, Calvert M, et al. Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards. Lancet Oncol. 2016;17:e510–4.

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MDS patient registries - achievements and challenges;Annals of Hematology;2024-08-23

2. Treatment characteristics and outcomes in lower-risk, non-del(5q) myelodysplastic syndromes: findings from a medical record review in the USA, Canada and Europe;Future Oncology;2024-08-14

3. Lower-Risk Myelodysplastic Syndromes: Putting Anemia Under the Spotlight;American Medical Journal Oncology;2024-07-16

4. Quality of life considerations in myelodysplastic syndrome: not only fatigue;Expert Review of Hematology;2024-07-12

5. Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome;Current Treatment Options in Oncology;2024-05-30